Types, Genetics, and Your Risk Profile
At a Glance
Protein S deficiency can result from making too little Protein S or from making a protein that does not work properly. Type I, II, and III results plus PROS1 inheritance describe the condition, but personal history, family history, and clotting triggers help determine individual risk.
Protein S deficiency is not a single, uniform condition. Because it is caused by changes in the PROS1 gene, the exact nature of that genetic change determines how much protein your body makes and how well it works [1]. Doctors use a combination of genetic data, your personal health history, and laboratory “phenotypes” (how the protein measures in your blood) to understand your specific risk profile.
The Three Laboratory Subtypes
When you receive your lab results, you may see a classification into one of three types. These are based on the balance between how much protein is present (the antigen) and how well it stops clotting (the activity) [2].
- Type I (Quantitative Defect): Your body simply doesn’t make enough Protein S. As a result, your total antigen, free antigen, and functional activity are generally all low [3].
- Type II (Qualitative Defect): Your body makes a normal amount of the protein (normal total antigen), but the protein itself is “broken” and doesn’t function correctly, leading to low activity [4][5].
- Type III (Redistribution Defect): In this type, your total antigen level is normal, but your free (active) antigen is low [6].
It is important to note that these labels are snapshots of your blood at a specific time. They can overlap, be altered by pregnancy, estrogen, illness, or lab assay interference, and they do not reliably translate into a strict ranking of disease severity [6].
The Role of the PROS1 Gene
All hereditary Protein S deficiency stems from variants in the PROS1 gene, which provides the instructions for making the protein [1].
In large population research studies, scientists classify these genetic variants into categories:
- High-Impact Variants (Loss-of-Function): These include nonsense, frameshift, or splice-site mutations. They essentially tell the body to stop making the protein halfway through. In research cohorts, groups of people with these variants tend to have significantly lower Protein S levels and face higher risks of blood clots [1].
- Missense Variants: These are genetic “variants” where one building block of the protein is swapped for another. These are more common. In population studies, groups with these variants often show milder effects on average [1]. However, certain specific missense variants (like Protein S Tokushima) can still cause significant functional problems (Type II) [5][7].
Important Context: These categories represent cohort-level research findings. Your doctor cannot calculate your exact lifetime risk or decide on your treatment based purely on whether your variant is “loss-of-function” or “missense.” Age, family history, prior clots, and acquired factors matter immensely. Furthermore, standard testing focuses on how Protein S works with Activated Protein C; while research shows Protein S also interacts with a pathway called TFPIα, assessing this is currently part of research, not routine clinical management [8].
Monoallelic vs. Biallelic Inheritance
Most people diagnosed with Protein S deficiency are heterozygous (or monoallelic), meaning they inherited one mutated gene from one parent and one healthy gene from the other [9].
- Monoallelic (Heterozygous): You have enough healthy protein to function well most of the time. Clinical penetrance is variable—this means that even within the same family, one person with the mutation might have a clot at age 20, while their parent with the same mutation never has one [9].
- Biallelic (Homozygous or Compound Heterozygous): This is an extremely rare and severe condition where both copies of the PROS1 gene are mutated [10]. This usually presents very early in life, sometimes as a severe newborn clotting condition called purpura fulminans, or as blood clots during childhood [10][11].
Ultimately, your genetic subtype is just one piece of the puzzle. A “negative” genetic test does not entirely rule out an inherited defect, and a “Variant of Uncertain Significance” (VUS) does not confirm one. Your personal and family history remain the strongest guides for your care.
Common questions in this guide
How are Type I, Type II, and Type III Protein S deficiency different?
What can a PROS1 genetic test tell me about Protein S deficiency?
Does having one altered PROS1 gene mean I will develop a blood clot?
What does biallelic Protein S deficiency mean?
Can pregnancy or illness change my Protein S deficiency test results?
What does a variant of uncertain significance mean in a PROS1 report?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Protein S Deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my laboratory report specify if I have Type I, II, or III deficiency, and how do my free and total antigen levels compare to the reference range?
- 2.Based on my genetic report, do I have a loss-of-function variant or a missense variant, and how does that fit with my personal and family history?
- 3.Am I a heterozygous (monoallelic) carrier, or do I have biallelic deficiency?
- 4.If my genetic test found a 'Variant of Uncertain Significance' (VUS), how does that change the way we interpret my low protein levels?
References
References (11)
- 1
Population-Scale Studies of Protein S Abnormalities and Thrombosis.
Chaudhry SA, Haj AK, Ryu J, et al.
JAMA 2025; (333(16)):1423-1432 doi:10.1001/jama.2025.0155.
PMID: 40029645 - 2
Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH.
Marlar RA, Gausman JN, Tsuda H, et al.
Journal of thrombosis and haemostasis : JTH 2021; (19(1)):68-74 doi:10.1111/jth.15109.
PMID: 33405382 - 3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies.
Hou L, Chen X, Xie H, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2025; (36(2)):51-57 doi:10.1097/MBC.0000000000001343.
PMID: 39918901 - 4
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency.
Xu F, Zhou X, Jin Y, et al.
Annals of hematology 2024; (103(2)):653-662 doi:10.1007/s00277-023-05607-6.
PMID: 38175252 - 5
Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent among young Japanese women.
Noguchi K, Nakazono E, Tsuda T, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2019; (30(8)):393-400 doi:10.1097/MBC.0000000000000854.
PMID: 31490209 - 6
An interactive human PROS1 variants database provides novel insights into the genetics and phenotypes of inherited protein S deficiency.
Hou Z, Liu F, Dong S, et al.
Journal of thrombosis and haemostasis : JTH 2026; (24(7)):2579-2592 doi:10.1016/j.jtha.2026.04.004.
PMID: 41967715 - 7
Gene analysis of six cases of congenital protein S deficiency and functional analysis of protein S mutations (A139V, C449F, R451Q, C475F, A525V and D599TfsTer13).
Taniguchi F, Morishita E, Sekiya A, et al.
Thrombosis research 2017; (151()):8-16 doi:10.1016/j.thromres.2016.12.018.
PMID: 28088608 - 8
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH.
Brinkman HJM, Ahnström J, Castoldi E, et al.
Journal of thrombosis and haemostasis : JTH 2021; (19(1)):281-286 doi:10.1111/jth.15108.
PMID: 33405384 - 9
A novel PROS1 mutation, c.74dupA, was identified in a protein S deficiency family.
Zhang Y, Yang H, Chen Q, et al.
Thrombosis research 2016; (148()):125-127 doi:10.1016/j.thromres.2016.11.003.
PMID: 27846449 - 10
[A family of hereditary protein S deficiency with the onset of pulmonary embolism and literature review].
Wei CJ, Guo CY, Li QR, Ye LP
Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(2)):134-138 doi:10.3760/cma.j.cn112140-20210915-00797.
PMID: 35090231 - 11
Vitamin K-Dependent Protein S: Beyond the Protein C Pathway.
Dahlbäck B
Seminars in thrombosis and hemostasis 2018; (44(2)):176-184 doi:10.1055/s-0037-1604092.
PMID: 28905350
This page explains Protein S deficiency types and PROS1 inheritance for informational purposes only and is not medical advice. Your hematologist or genetic counselor should interpret your laboratory and genetic results and assess your individual clot risk.